SOX9 and hepatocellular carcinoma: Its oncogenic properties have been demonstrated in a variety of malignancies including HCC [96], and cell cycle protein-dependent kinase 2 (CDK2) [97] interacts with SOX9 to promote cell cycle progression [98].